002821 Asymchem Laboratories(Tianjin)Co.,Ltd.
Closed 12-09 15:00:00
92.76
-0.56
-0.60%
High95.00Low92.65Vol3.56M
Open93.05D1 Closing93.32Amplitude2.52%
Mkt Cap33.49BTradable Cap29.40BTotal Shares361.00M
T/O334.00MT/O Rate1.12%Tradable Shares317.00M
P/B1.94ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

AsymBio Launches Commercial Operations at Fengxian Base
Reuters  ·  12-08 13:00
AsymBio Launches Commercial Operations at Fengxian Base
Asymchem (06821) Rises Nearly 3% Before Noon as Shanghai Fengxian Base Officially Commences Operations, Focusing on NDCs and Other Fields
Stock News  ·  12-08 11:40
Asymchem (06821) Rises Nearly 3% Before Noon as Shanghai Fengxian Base Officially Commences Operations, Focusing on NDCs and Other Fields
Asymchem Laboratories (06821) Grants 291,400 Restricted A Shares
Stock News  ·  11-27
Asymchem Laboratories (06821) Grants 291,400 Restricted A Shares
Asymchem Laboratories Tianjin Files Next Day Disclosure Return to HKEX for Share Capital Increase with 331,597,760 New Shares Issued
Reuters  ·  11-27
Asymchem Laboratories Tianjin Files Next Day Disclosure Return to HKEX for Share Capital Increase with 331,597,760 New Shares Issued
JPMorgan Reduces Stake in Asymchem (06821) by 70,700 Shares at HK$84.7 per Share
Stock News  ·  11-18
JPMorgan Reduces Stake in Asymchem (06821) by 70,700 Shares at HK$84.7 per Share
JPMorgan Increases Stake in Asymchem (06821) by 61,900 Shares at Average Price of HK$83.89 per Share
Stock News  ·  11-13
JPMorgan Increases Stake in Asymchem (06821) by 61,900 Shares at Average Price of HK$83.89 per Share
Norges Bank Increases Stake in Asymchem (06821) by 65,200 Shares at HK$84.39 per Share
Stock News  ·  11-11
Norges Bank Increases Stake in Asymchem (06821) by 65,200 Shares at HK$84.39 per Share
JPMorgan Reduces Stake in Asymchem by 202,000 Shares at HK$83.43 per Share
Deep News  ·  11-10
JPMorgan Reduces Stake in Asymchem by 202,000 Shares at HK$83.43 per Share
JPMorgan Reduces Stake in Asymchem (06821) by 202,000 Shares at HK$83.43 per Share
Stock News  ·  11-07
JPMorgan Reduces Stake in Asymchem (06821) by 202,000 Shares at HK$83.43 per Share
Asymchem (06821) Rises Over 3% as Q1-Q3 Net Profit Grows 12.66% YoY, Emerging Businesses Poised as Core Growth Driver
Stock News  ·  11-07
Asymchem (06821) Rises Over 3% as Q1-Q3 Net Profit Grows 12.66% YoY, Emerging Businesses Poised as Core Growth Driver
Norges Bank Increases Stake in Asymchem (06821) by 62,300 Shares at HK$84.51 per Share
Stock News  ·  11-06
Norges Bank Increases Stake in Asymchem (06821) by 62,300 Shares at HK$84.51 per Share
Norges Bank Increases Stake in Asymchem (06821) by 213,700 Shares at HK$86.6 per Share
Stock News  ·  11-03
Norges Bank Increases Stake in Asymchem (06821) by 213,700 Shares at HK$86.6 per Share
Schroders PLC Reduces Stake in Asymchem (06821) by 28,100 Shares at HK$86.16 per Share
Stock News  ·  11-03
Schroders PLC Reduces Stake in Asymchem (06821) by 28,100 Shares at HK$86.16 per Share
JPMorgan Reduces Stake in Asymchem (06821) by 19,400 Shares at HK$88.28 per Share
Stock News  ·  10-31
JPMorgan Reduces Stake in Asymchem (06821) by 19,400 Shares at HK$88.28 per Share
Schroders PLC Increases Stake in ASYMCHEM (06821) by 87,400 Shares at HK$88.31 per Share
Stock News  ·  10-31
Schroders PLC Increases Stake in ASYMCHEM (06821) by 87,400 Shares at HK$88.31 per Share
BRIEF-Asymchem Laboratories (Tianjin) Posts Qtrly Profit Attributable Rmb182.8 Million
Reuters  ·  10-30
BRIEF-Asymchem Laboratories (Tianjin) Posts Qtrly Profit Attributable Rmb182.8 Million
Norges Bank Increases Stake in Asymchem (06821) by 132,200 Shares at HK$89.71 per Share
Stock News  ·  10-30
Norges Bank Increases Stake in Asymchem (06821) by 132,200 Shares at HK$89.71 per Share
Asymchem Laboratories (Tianjin) - Qtrly Profit Attributable RMB182.8 Mln
THOMSON REUTERS  ·  10-30
Asymchem Laboratories (Tianjin) - Qtrly Profit Attributable RMB182.8 Mln
Asymchem Laboratories (Tianjin) - Qtrly Operating Revenue RMB1441.6mln
THOMSON REUTERS  ·  10-30
Asymchem Laboratories (Tianjin) - Qtrly Operating Revenue RMB1441.6mln
BRIEF-Citigroup's Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Decreases To 2.52% On Oct 13, HKEX Says
Reuters  ·  10-17
BRIEF-Citigroup's Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Decreases To 2.52% On Oct 13, HKEX Says

Introduction

Company Name.
凯莱英医药集团(天津)股份有限公司
Industry:
医药制造业
Listing Date:
2016-11-18
Main Business:
　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。截至报告期末公司共有国内外已授权专利538项，其中国内专利423项，国外专利115项，其中183项在合成生物领域，204项在连续反应技术领域。
Issue price:
30.53